Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy

Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy
复制标题

DOI:
10.1016/j.ijrobp.2007.10.056
复制
发表时间:
2008-03-01
影响因子:
7
通讯作者:
Liao, Zhongxing
Liao, Zhongxing
中科院分区:
医学1区
文献类型:
--
作者:
Wei, Xiong;Liu, H. Helen;Liao, Zhongxing

文献摘要

被引文献

相似文献

目的:确定临床和剂量学因素影响心包积液(PCE)的风险与明确的同步化疗和放疗(RT)治疗的食管癌患者的治疗方法和材料:资料为101例不能手术的食管癌患者同步化疗和RT从2000年至2003年在我们的机构进行了分析。PCE从随访胸部计算机断层扫描和放射学报告中得到证实,从RT结束时开始计算无PCE。使用对数秩检验来确定影响无PCE的临床和剂量学因素。结果:101例患者中PCE的粗率为27.7%(28/101)。中位时间发生的PCE为5.3个月(范围,1.0-16.7个月)后RT。没有临床因素的研究被发现显着影响PCE的风险。在单变量分析中,心包和心脏的广泛剂量-体积直方图参数与PCE风险相关,包括心包的平均剂量、接受剂量大于3戈伊(V3)至大于50戈伊(V50)的心包体积和接受治疗的心脏体积大于32-38戈伊。多因素分析选择V30作为唯一与PCE风险显著相关的参数。结论:高剂量辐射心包可能强烈增加PCE的风险。这种风险可以通过最小化被照射的心包和心脏的剂量体积来降低。(c)2008年爱思唯尔公司
Purpose: To identify clinical and dosimetric factors influencing the risk of pericardial effusion (PCE) in patients with inoperable esophageal cancer treated with definitive concurrent chemotherapy and radiation therapy (RT).Methods and Materials: Data for 101 patients with inoperable esophageal cancer treated with concurrent chemotherapy and RT from 2000 to 2003 at our institution were analyzed. The PCE was confirmed from follow-up chest computed tomography scans and radiologic reports, with freedom from PCE computed from the end of RT. Log-rank tests were used to identify clinical and dosimetric factors influencing freedom from PCE. Dosimetric factors were calculated from the dose-volume histogram for the whole heart and pericardium.Results: The crude rate of PCE was 27.7% (28 of 101). Median time to onset of PCE was 5.3 months (range, 1.0-16.7 months) after RT. None of the clinical factors investigated was found to significantly influence the risk of PCE. In univariate analysis, a wide range of dose-volume histogram parameters of the pericardium and heart were associated with risk of PCE, including mean dose to the pericardium, volume of pericardium receiving a dose greater than 3 Gy (V3) to greater than 50 Gy (V50), and heart volume treated to greater than 32-38 Gy. Multivariate analysis selected V30 as the only parameter significantly associated with risk of PCE.Conclusions: High-dose radiation to the pericardium may strongly increase the risk of PCE. Such a risk may be reduced by minimizing the dose-volume of the irradiated pericardium and heart. (c) 2008 Elsevier Inc.